Boehringer Ingelheim and Vitae type 2 diabetes drug misses endpoint
1 July 2015 | By Victoria White
Vitae has announced top-line efficacy results from the metformin arm of a trial of BI187004/VTP-34072 in the treatment of patients with type 2 diabetes...